Low Plasma Vitamin D is Associated with Adverse Colorectal Cancer Survival After Surgical Resection, Independent of Systemic Inflammatory Response
Overview
Authors
Affiliations
Objective: We assessed the effect of surgical resection of colorectal cancer (CRC) on perioperative plasma vitamin D (25OHD) and C-reactive protein (CRP) level. We investigated the relationship between circulating vitamin D level and CRC survival.
Design: We sequentially sampled 92 patients undergoing CRC resection, and measured plasma 25OHD and CRP. For survival analyses, we assayed 25OHD and CRP in two temporally distinct CRC patient cohorts (n=2006, n=2100) and investigated the association between survival outcome, circulating vitamin D and systemic inflammatory response.
Results: Serial sampling revealed a postoperative fall (mean 17.3 nmol/L; p=3.6e-9) in plasma 25OHD (nadir days 1-2). CRP peaked 3-5 days postoperatively (143.1 mg/L; p=1.4e-12), yet the postoperative fall in 25OHD was independent of CRP. In cohort analyses, 25OHD was lower in the 12 months following operation (mean=48.8 nmol/L) than preoperatively (54.8 nmol/L; p=1.2e-5) recovering after 24 months (52.2 nmol/L; p=0.002). Survival analysis in American Joint Committee on Cancer stages I-III demonstrated associations between 25OHD tertile and CRC mortality (HR=0.69; 95% CI 0.46 to 0.91) and all-cause mortality (HR=0.68; 95% CI 0.50 to 0.85), and was independent of CRP. We observed interaction effects between plasma 25OHD and rs11568820 genotype (functional polymorphism) with a strong protective effect of higher 25OHD only in patients with GG genotype (HR=0.51; 95% CI 0.21 to 0.81). We developed an online tool for predicted survival (https://apps.igmm.ed.ac.uk/mortalityCalculator/) that incorporates 25OHD with clinically useful predictive performance (area under the curve 0.77).
Conclusions: CRC surgery induces a fall in circulating 25OHD. Plasma 25OHD level is a prognostic biomarker with low 25OHD associated with poorer survival, particularly in those with rs11568820 GG genotype. A randomised trial of vitamin D supplementation after CRC surgery has compelling rationale.
Cartes-Velasquez R, Vera A, Torres-Quevedo R, Medrano-Diaz J, Perez A, Munoz C Nutrients. 2024; 16(23).
PMID: 39683528 PMC: 11643987. DOI: 10.3390/nu16234134.
Zheng B, Chen J, Gong X BMC Surg. 2024; 24(1):180.
PMID: 38867218 PMC: 11167935. DOI: 10.1186/s12893-024-02473-5.
Zhang X, He Y, Li X, Shraim R, Xu W, Wang L Br J Cancer. 2024; 130(9):1585-1591.
PMID: 38480934 PMC: 11058806. DOI: 10.1038/s41416-024-02643-5.
Vitamin D Status, Genotype, and Colorectal Cancer Survival: Population-Based Patient Cohort.
Gwenzi T, Schrotz-King P, Schottker B, Hoffmeister M, Brenner H Nutrients. 2023; 15(12).
PMID: 37375621 PMC: 10305330. DOI: 10.3390/nu15122717.
Wang Q, Ma C, Yuan C, Shi Q, Wolpin B, Zhang Y Clin Cancer Res. 2023; 29(14):2621-2630.
PMID: 37289007 PMC: 10524689. DOI: 10.1158/1078-0432.CCR-23-0447.